Related Topics News -

     
 Title only   |   Print 
     
金斯瑞收到禮新就抗PD-1單域抗體許可協議項下2.14億美元付款

2025-06-30T  
《大行》大摩列康龍化成為中型CRO/CDMO首選股 長期看好昭衍泰格

2025-06-10T  
金斯瑞:傳奇生物將於美國及歐洲披露CARVYKTI最新資料

2025-05-23T  
金斯瑞斥2.25億美元增持CDMO服務附屬Probio Cayman

2025-04-28T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.